FDA Broadens Clearance For Agendia's MammaPrint(R)

[News]

Agendia, a world leader in molecular cancer diagnostics, announced that the US Food and Drug Administration (FDA) cleared its MammaPrint breast cancer recurrence test for all ages. MammaPrint is the only FDA-cleared breast cancer recurrence test available to patients and physicians...

More... (http://mnt.to/f/3vF6)